This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hacker, E. Articles by Walker, G. Search for Related Content PubMed PubMed Citation Articles by Hacker, E. Articles by Walker, G.

Spontaneous and UV Radiation–Induced Multiple Metastatic Melanomas in Cdk4^R24C/R24C/TPras Mice

¹ Queensland Institute of Medical Research; ² Centre for Immunology and Cancer Research, Brisbane, Queensland, Australia; ³ University of Tasmania, School of Medicine, Hobart, Tasmania, Australia; ⁴ Division of Radiation and Cancer Biology, Stanford University, Stanford, California; and ⁵ Molecular Oncology, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain

Requests for reprints: Graeme Walker, Queensland Institute of Medical Research, 300 Herston Road, Herston, QLD 4006, Australia. Phone: 61-7-3362-0308; Fax: 61-7-3845-3508; E-mail: graemeW{at}qimr.edu.au.

Human melanoma susceptibility is often characterized by germ-line inactivating CDKN2A (INK4A/ARF) mutations, or mutations that activate CDK4 by preventing its binding to and inhibition by INK4A. We have previously shown that a single neonatal UV radiation (UVR) dose delivered to mice that carry melanocyte-specific activation of Hras (TPras) increases melanoma penetrance from 0% to 57%. Here, we report that activated Cdk4 cooperates with activated Hras to enhance susceptibility to melanoma in mice. Whereas UVR treatment failed to induce melanomas in Cdk4^R24C/R24C mice, it greatly increased the penetrance and decreased the age of onset of melanoma development in Cdk4^R24C/R24C/TPras animals compared with TPras alone. This increased penetrance was dependent on the threshold of Cdk4 activation as Cdk4^R24C/+/TPras animals did not show an increase in UVR-induced melanoma penetrance compared with TPras alone. In addition, Cdk4^R24C/R24C/TPras mice invariably developed multiple lesions, which occurred rarely in TPras mice. These results indicate that germ-line defects abrogating the pRb pathway may enhance UVR-induced melanoma. TPras and Cdk4^R24C/R24C/TPras tumors were comparable histopathologically but the latter were larger and more aggressive and cultured cells derived from such melanomas were also larger and had higher levels of nuclear atypia. Moreover, the melanomas in Cdk4^R24C/R24C/TPras mice, but not in TPras mice, readily metastasized to regional lymph nodes. Thus, it seems that in the mouse, Hras activation initiates UVR-induced melanoma development whereas the cell cycle defect introduced by mutant Cdk4 contributes to tumor progression, producing more aggressive, metastatic tumors. (Cancer Res 2006; 66(6): 2946-52)

This article has been cited by other articles:

				K. S.M. Smalley, M. Lioni, M. D. Palma, M. Xiao, B. Desai, S. Egyhazi, J. Hansson, H. Wu, A. J. King, P. Van Belle, et al. Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas Mol. Cancer Ther., September 1, 2008; 7(9): 2876 - 2883. [Abstract] [Full Text] [PDF]

				L. Chin, L. A. Garraway, and D. E. Fisher Malignant melanoma: genetics and therapeutics in the genomic era. Genes & Dev., August 15, 2006; 20(16): 2149 - 2182. [Abstract] [Full Text] [PDF]